Managers
Northrop Grumman Corporation has closed its acquisition of Orbital ATK, a specialist in aerospace and defence technologies. Orbital ATK is now Northrop Grumman Innovation Systems, a new, fourth business sector.
Northrop Grumman’s board of directors has elected Blake Larson as corporate vice president and president of Northrop Grumman Innovation Systems, reporting to Kathy Warden, Northrop Grumman’s president and chief operating officer. Larson previously served as the chief operating officer of Orbital ATK.
“We welcome Orbital ATK’s talented employees,” says Wes Bush, chairman and chief executive officer, Northrop Grumman. “We are delighted to have them join the Northrop Grumman team,
Fondo Agroalimentare Italiano (FAI) has held its first closing with commitments of nearly EUR40 million. The Fund is expected to reach its EUR50 million target and maintains its EUR70 million hard cap.
Sponsored by Unigrains, the Fund’s subscribers include French, Italian and Swiss institutional investors and family offices as well as several Italian entrepreneurs.
FAI invests in minority stakes either in growth capital transactions or in buyout transactions as a sector specialist, in the capital of Italian agri-food SMEs with sales generally between EUR10 million and EUR150 million. These investments go towards financing the development of companies via external
Private equity firm Silverfleet Capital has agreed to sell Ipes, a provider of outsourced service,s including fund administration, to the European private equity sector, to Apex Group Ltd.
The transaction, which is expected to generate a 3.8-times money multiple and 30 per cent IRR for Silverfleet once completion, adds USD165 billion in assets under administration to Apex’s portfolio.
Ipes was founded in 1998 and pioneered a specialist approach to fund administration within the European Private Equity market. Ipes’ team of 265 people located in five European offices works with 195 clients and provides administration and depositary oversight to 390
NextGen Growth Partners (NGP), a Chicago-based private equity firm that taps top entrepreneurs to acquire and grow businesses, has held the final close of its inaugural fund, above its original USD50 million target.
“We are thrilled with the ultimate investor group in this fund,” says Brian O’Connor, NGP Founder and Managing Partner. “It establishes a network of strategic investors and advisors that will be instrumental in the success of our strategy.”
NGP’s business model is to identify and mentor top talent within Chicago’s world-class entrepreneurial community – particularly business school alumni from the University of Chicago Booth School of
Kerry Logistics Network Limited has acquired a majority stake in Milan-based logistics company Saga Italia, as part of its ongoing global expansion strategy.
The acquisition will also add three new countries to Kerry Logistics’ network – the Republic of the Congo, Uganda, and Egypt, as well as new offices in Kazakhstan, Turkmenistan, United Arab Emirates, Russia, and the US.
Founded in 1985, Saga Italia provides end-to-end solutions tailored to its customers’ project requirements. More than 150 logistics professionals manage projects for multinational corporations across the globe, particularly for customers in the oil and gas industry. Saga Italia’s comprehensive range
Great Rock Capital, an asset-focused commercial finance company specialising in middle market lending, has completed a GBP25 million secured term loan for Zacky & Sons Poultry, a vertically integrated grower, processor, and distributor of premium poultry products.
In addition, Great Rock Capital partnered with GemCap Solutions, an innovative lending firm that provides senior-secured, commercial asset-based loans, which provided a GBP16 million revolving loan.
The capital will enable Zacky & Sons to refinance existing senior indebtedness and fund capital expenditures to expand its production facilities to support the company’s growth.
“We are excited about our partnership with Great Rock
Gide has advised ENYO Pharma on its EUR40 million Series B round of financing from US and European investors.
ENYO Pharma is a clinical stage biotech company developing innovative drug candidates by mimicking virus strategies to modulate host cellular functions. This very significant funding will enable the company to finance the two first Phase II clinical trials of its EYP001 asset in both chronic HBV and NASH. A second asset is also expected to enter the clinic by 2019.
This round was led by OrbiMed, followed by Andera Partners and Bpifrance Large Venture as new shareholders. Existing shareholders Sofinnova
Target Global, a Berlin-based international venture capital fund with USD600m in assets under management, is launching a dedicated fund to invest in next-generation mobility and transportation.
Its unique evergreen structure means that, unlike traditional VC funds which have a fixed end-point, this one will run indefinitely. The fund can deploy up to USD300 million in capital, providing investors with a long-term interest in disruptive changes across the entire mobility spectrum. The primary targets for investment will be European and Israeli startups that focus on innovation and technology in automotive, private & public transportation, logistics & delivery and related cross-services.
Venture investing platform Portfolia Funds has launched its sixth fund – The Portfolia FemTech Fund – which will invest exclusively in emerging technologies, products and services focused on improving women’s health and wellness.
Frost and Sullivan recently published a report stating that FemTech will be a USD50 billion market by 2025. Spurred on by rapid innovation in the health space, a positive regulatory environment and the fact that women now control 80 per cent of healthcare decisions in the US household, FemTech is predicted to be the next big disruptor in the global healthcare market. While the benefits of FemTech
Marqeta, an open-API card issuing platform, has raised USD45 million in new funding in a round led by ICONIQ Capital, with participation from Goldman Sachs and existing investors, bringing the firm’s total funding to USD116 million.
“Marqeta is the clear market leader in modern card issuing, and we’re thrilled to be part of their already phenomenal growth story,” says Will Griffith, partner at ICONIQ Capital. “They have the most advanced card issuing technology in the category, and they have assembled an extraordinary team of industry leaders.”
Marqeta will leverage the investment, along with the USD25 million it took in
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
